Notably, pathogenic variants in the GBA gene coding for glucocerebrosidase have been implicated in increased susceptibility to parkinsonism, occasionally constituting the presenting phenotype in carriers [40,41,43,134], who have a similar risk of parkinsonism as patients with Gaucher disease. This evidence concerns the gene GBA1 and Parkinson disease.